Study: Riskier surgeries for back pain raise costs

Study: Riskier surgeries for back pain raise costs
CHICAGO (AP) — A new study suggests a risky type of back surgery is on the rise in older patients — and many of the surgeries are unnecessary. The study in Medicare patients also finds the riskiest procedures are driving up costs. The patients in the study had [...]

Lack of early treatment cause of back pain : Study

Lack of early treatment cause of back pain : Study
Mumbai, Apr 4 : Backpain, that afflicts 60 per cent of Indians at least once in their lifetime, is increasing because of lack of preventive management and carelessness, a study conducted to find out the psychosocial and demographic factors contributing to the high incidence of lower [...]

Study shows drinking cherry juice can boost recovery time for Marathon runners

Study shows drinking cherry juice can boost recovery time for Marathon runners
Runners taking part in this month’s London Marathon can boost their recovery time by drinking tart cherry juice before and after the race, according to a researcher at Northumbria University.
Read more on News-Medical-Net

Southern Illinois University professor wins NIH grant to study role of surgical procedure on Type II diabetes

Southern Illinois University professor wins NIH grant to study role of surgical procedure on Type II diabetes
Gastric bypass surgery, thought of by many as the last hope of morbidly obese people for losing weight, has many other benefits researchers are only beginning to understand.
Read more on News-Medical-Net

Biogen Idec and Elan Enroll First Patient in Large, Well-Controlled Head-to-Head Study of Multiple Sclerosis Treatments

Biogen Idec and Elan Enroll First Patient in Large, Well-Controlled Head-to-Head Study of Multiple Sclerosis Treatments
CAMBRIDGE, Mass.—-Biogen Idec and Elan Corporation, plc today announced enrollment of the first patient in a global Phase IIIb, randomized, rater-blinded, active-controlled study designed to evaluate switching to TYSABRI® from Copaxone® or Rebif® in patients with relapsing remitting multiple sclerosis [...]

Portola Pharmaceuticals And Merck Announce That Phase 2 Study Showed Investigational Factor Xa Inhibitor, Betrixaban …

Portola Pharmaceuticals And Merck Announce That Phase 2 Study Showed Investigational Factor Xa Inhibitor, Betrixaban …
Portola Pharmaceuticals and Merck today announced the results of EXPLORE-Xa, a Phase 2 exploratory, dose finding study of betrixaban, an investigational oral direct Factor Xa inhibitor. Results showed that a once-daily dose of oral betrixaban, given to patients with non-valvular [...]

Study Finds Little Effect Of Soy Isoflavones On Bone Loss In Postmenopausal Women

Study Finds Little Effect Of Soy Isoflavones On Bone Loss In Postmenopausal Women
New study expands upon earlier research”Our six-month preliminary study, published in 2000, indicated that soy protein, rich in isoflavones, exerted the greatest impact in slowing the loss of bone mineral density in the lumbar spine,” Alekel said. “But we believed that we needed [...]

« Previous Page